Recap: Kiniksa Pharmaceuticals Q3 Earnings

Kiniksa Pharmaceuticals KNSA reported its Q3 earnings results on Tuesday, November 1, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Kiniksa Pharmaceuticals posted an EPS of $3.18.

Revenue was up $87.04 million from the same period last year.

Last quarter the company beat on EPS by $0.15 which was followed by a 9.46% increase in the share price the next day.

Here's a look at Kiniksa Pharmaceuticals's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	-0.44	-0.41	-0.42	-0.65
EPS Actual	-0.29	-0.36	-0.53	-0.44
Revenue Estimate	28.55M	22.77M	20.72M	10.18M
Revenue Actual	26.97M	32.19M	18.75M	12.10M

To track all earnings releases for Kiniksa Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar